Intelligent Bio Solutions Inc. announced a new global distribution agreement with SMARTOX, a Texas-based leader in drug and alcohol screening services. This agreement will bring SMARTOX's SmarTest Patch drug detection product to international markets outside of the United States and Canada.
This partnership builds on the long-standing relationship between INBS and SMARTOX, which already distributes INBS’s Intelligent Fingerprinting Drug Testing Solution in the U.S. Forensic Use Only market. The SmarTest Patch introduces continuous sweat-based drug detection over an extended period, complementing INBS's existing offerings.
The agreement supports INBS’s international growth strategy and creates an additional revenue stream, aligning with its broader expansion goals. The global drug testing market is projected to reach approximately $18.6 billion by 2030, positioning INBS to offer greater flexibility to customers with two complementary non-invasive products.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.